Hospital Avicenne
Also known as: AP-HP Avicenne Hospital, Department of Internal Medicine, ESH Hypertension European Excellence Centre | Avicenne Hospital | Avicenne Hospital, 93 000 Bobigny | Avicenne Hospital-APHP | Avicenne University Hospital | CRNH - CRV Avicenne Hospital | Hôpital Avicenne | Hopital Avicenne | Hopital Avicenne, APHP | Hôpital Avicenne, APHP BOBIGNY | Hopital Avicenne BOBIGNY | HOPITAL AVICENNE BOBIGNY | HOPITAL AVICENNE - BOBIGNY CEDEX | Hopital Avicenne, Service des maladies infectieuses, Paris, france | Hospital Avicenne | Robert Benamouzig | SAMU 93 - AVICENNE HOSPITAL
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2002Last known activity
Jun 30, 2025
Timeline
1930s
- Jan 1, 1935
Hospital Avicenne— Founded
Drugs by trial phase (35 distinct, 22 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Angiodysplasia
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Coronary Artery Disease
- Coronary Disease
- Fibrosis
- Hepatitis C
- Hepatitis C, Chronic
- Hyperkalemia
- Leukemia
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Liver Cirrhosis
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Meningitis
- Meningitis, Cryptococcal
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Pancreatitis
- Pancreatitis, Chronic
- Urticaria
Recent trials (32)
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT04748796CollaboratorN/AFeb 1, 2021
- NCT04113226Overall official - principal investigatorPhase 2Oct 31, 2019
- NCT04012138Overall official - principal investigatorPhase 4Oct 1, 2019
- NCT02319200Overall official - principal investigatorPhase 3Jun 1, 2015
- NCT02550106Overall official - principal investigatorPhase 4Apr 1, 2015
- NCT02351297Overall official - principal investigatorN/AJan 1, 2015
- NCT02351297Lead sponsorN/AJan 1, 2015
- NCT02351297Reponsible party - principal investigatorN/AJan 1, 2015
- NCT02197221Overall official - principal investigatorPhase 3Jan 1, 2015
- NCT02309450Overall official - principal investigatorPhase 2Dec 1, 2014
- NCT02354794CollaboratorN/AFeb 1, 2014
- NCT02354794Overall official - principal investigatorN/AFeb 1, 2014
- NCT02352740CollaboratorN/AMar 1, 2013
Details
- Founded
- Bobigny, FR Jan 1, 1935
- Last known activity
- Jun 30, 2025